Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Queensland Health
Chinese Patent Office
Deloitte
Argus Health
Accenture
Fish and Richardson
UBS
Mallinckrodt

Generated: April 25, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 088150

« Back to Dashboard

NDA 088150 describes PENTOLAIR, which is a drug marketed by Bausch And Lomb and Pharmafair and is included in three NDAs. It is available from three suppliers. Additional details are available on the PENTOLAIR profile page.

The generic ingredient in PENTOLAIR is cyclopentolate hydrochloride. There are two drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the cyclopentolate hydrochloride profile page.
Summary for 088150
Tradename:PENTOLAIR
Applicant:Pharmafair
Ingredient:cyclopentolate hydrochloride
Patents:0
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 088150

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:SOLUTION/DROPS;OPHTHALMICStrength1%
Approval Date:Feb 25, 1983TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
McKinsey
Teva
Daiichi Sankyo
Federal Trade Commission
Deloitte
Cerilliant
Julphar
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.